Thrombosis risk stratification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. | Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor. | ||
==Risk factors== | ==Risk factors== | ||
Line 14: | Line 14: | ||
**[[Obesity]] | **[[Obesity]] | ||
**[[Pregnancy]] | **[[Pregnancy]] | ||
** | **Immobilization | ||
*'''Medical''' | *'''Medical''' |
Revision as of 02:28, 4 September 2011
Thrombosis Microchapters |
Site of Thrombosis |
---|
Differentiating Thrombosis from other Diseases |
Diagnosis |
Treatment |
Thrombosis risk stratification On the Web |
Risk calculators and risk factors for Thrombosis risk stratification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Overview
Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor.
Risk factors
- Medical
- Familial
- Antithrombin III deficiency
- Protein C deficiency/Protein S deficiency
- APC resistance (Factor V Leiden)
- Dysfibrogenemia
- Hypoplasminogenemia
- Familial homocysteinemia
Source
http://www.bmj.com/content/343/bmj.d4656.full
cs:Trombóza de:Thrombose eo:Trombozo it:Trombosi he:תרומבוס ms:Trombotik nl:Trombose fi:Verihiutale